Table 1 Characteristics of VITAL cohort participants included in this study
From: Frailty is related to serum inflammageing markers: results from the VITAL study
Total | Young (25–49 years) | Middle age (50–64 years) | Older (≥ 65 years) | |
|---|---|---|---|---|
N | 317 | 63 | 95 | 159 |
Age median (IQR) | 65 (54–75) | 35 (29–42) | 58 (55–61) | 75 (69–81) |
Sex % female | 54 | 67 a | 59 | 47 |
BMI kg/m2, median (IQR) | 24.6 (22.4–27.5) | 24.0 a b (21.5–25.5) | 24.0 (21.8–26.5) | 25.3 (23.4–28.6) |
CMV %positive / %negative | 48/51 | 42/57 | 51/47 | 50/48 |
EBV %positive / %negative | 83/14 | 76/18 | 87/13 | 83/13 |
Smoking, %smoking > 4 cigarettes/week | 3.7 | 1.6 | 3.2 | 5.0 |
Frailty index median (IQR) | 0.13 (0.08–0.20) | 0.06 a b (0.03–0.10) | 0.10 c (0.06–0.14) | 0.18 (0.13–0.26) |
EQ-5D-3L median (IQR) | 1 (0.81–1) | 1 a (0.84–1) | 1 c (0.84–1) | 0.84 (0.81–1) |
SF-36 PF median (IQR) | 95 (80–100) | 100 a b (95–100) | 95 c (90–100) | 85 (65–95) |
SF-36 HG median (IQR) | 70 (60–80) | 75 a (70–85) | 75 c (65–85) | 65 (55–75) |
Health rating median (IQR) | 8.0 (7.0–8.5) | 8.0 (7.5–9.0) | 8.0 (7.5–9.0) | 8.0 (7.0–8.5) |
Number of medications median (IQR) | 2 (0–4) | 0 a (0–1) | 1 c (0–2) | 4 (2–6) |